XML 45 R32.htm IDEA: XBRL DOCUMENT v3.19.1
Shareholders' Equity (Tables)
12 Months Ended
Feb. 02, 2019
Share-based Compensation [Abstract]  
Schedule of warrants outstanding [Table Text Block]
The following table summarizes information regarding Warrants outstanding at February 2, 2019:
Grant Date
 
Warrants Outstanding
 
Warrants Exercisable
 
Exercise Price
(Per Share)
 
Expiration Date
September 19, 2016
 
2,976,190

 
2,976,190

 
$2.90
 
September 19, 2021
November 10, 2016
 
333,873

 
333,873

 
$3.00
 
November 10, 2021
January 23, 2017
 
489,302

 
489,302

 
$1.76
 
January 23, 2022
March 16, 2017
 
50,000

 
50,000

 
$1.92
 
March 16, 2022
November 27, 2018
 
500,000

 
125,000

 
$1.05
 
November 27, 2025
November 27, 2018
 
1,000,000

 

 
$3.00
 
November 27, 2025
Schedule of non-vested restricted stock award activity [Table Text Block]
A summary of the status of the Company’s non-vested restricted stock award activity as of February 2, 2019 and changes during the twelve-month period then ended is as follows:
 
 
Restricted Stock
 
 
Shares
 
Weighted
Average
Grant Date
Fair Value
Non-vested outstanding, February 3, 2018
 

 
$

Granted
 
1,500,000

 
$
0.94

Vested
 
(500,000
)
 
$
0.94

Non-vested outstanding, February 2, 2019
 
1,000,000

 
$
0.94

Schedule of stock option valuation assumptions [Table Text Block]
The fair value of each time-based vesting option award is estimated on the date of grant using the Black-Scholes option pricing model that uses assumptions noted in the following table. Expected volatilities are based on the historical volatility of the Company's stock. Expected term is calculated using the simplified method taking into consideration the option's contractual life and vesting terms. The Company uses the simplified method in estimating its expected option term because it believes that historical exercise data cannot be accurately relied upon at this time to provide a reasonable basis for estimating an expected term due to the extreme volatility of its stock price and the resulting unpredictability of its stock option exercises. The risk-free interest rate for periods within the contractual life of the option is based on the U.S. Treasury yield curve in effect at the time of grant. Expected dividend yields were not used in the fair value computations as the Company has never declared or paid dividends on its common stock and currently intends to retain earnings for use in operations.
 
Fiscal 2018
 
Fiscal 2017
 
Fiscal 2016
Expected volatility
72%
-
78%
 
81%
 
81
%
-
84%
Expected term (in years)
6 years
 
6 years
 
6 years
Risk-free interest rate
2.8%
-
3.0%
 
2.0%
-
2.2%
 
1.4%
-
2.2%
Summary of stock option activity [Table Text Block]
A summary of the status of the Company’s stock option activity as of February 2, 2019 and changes during the year then ended is as follows:
 
 
2011
Incentive
Stock
Option
Plan
 
Weighted
Average
Exercise
Price
 
2004
Incentive
Stock
Option
Plan
 
Weighted
Average
Exercise
Price
Balance outstanding, February 3, 2018
 
3,384,000

 
$
1.64

 
112,000

 
$
4.86

Granted
 
2,264,000

 
$
1.02

 

 
$

Exercised
 
(165,000
)
 
$
1.10

 

 
$

Forfeited or canceled
 
(724,000
)
 
$
1.67

 
(5,000
)
 
$
4.62

Balance outstanding, February 2, 2019
 
4,759,000

 
$
1.36

 
107,000

 
$
4.87

Options exercisable at February 2, 2019
 
1,554,000

 
$
1.84

 
107,000

 
$
4.87

Schedule of stock options, vested and expected to vest, outstanding [Table Text Block]
The following table summarizes information regarding stock options outstanding at February 2, 2019:
 
 
Options Outstanding
 
Options Vested or Expected to Vest
Option Type
 
Number of
Shares
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Contractual
Life
(Years)
 
Aggregate
Intrinsic
Value
 
Number of
Shares
 
Weighted
Average
Exercise
Price
 
Weighted
Average
Remaining
Contractual
Life
(Years)
 
Aggregate
Intrinsic
Value
2011 Incentive:
 
4,759,000

 
$
1.36

 
8.2
 
$

 
4,396,000

 
$
1.38

 
8.2
 
$

2004 Incentive:
 
107,000

 
$
4.87

 
4.7
 
$

 
107,000

 
$
4.87

 
4.7
 
$

Schedule of grant date fair value assumptions, market-based restricted stock performance units [Table Text Block]
Grant date fair values were determined using a Monte Carlo valuation model based on assumptions as follows:
 
Fiscal 2018
 
Fiscal 2017
 
Fiscal 2016
Total grant date fair value
$859,000
 
$860,000
 
$645,000
Total grant date fair value per share
$1.07
-
$1.30
 
$1.53
 
$0.98
-
$1.82
Expected volatility
73%
-
76%
 
75%
 
71%
-
77%
Weighted average expected life (in years)
3 years
 
3 years
 
3 years
Risk-free interest rate
2.4%
-
2.7%
 
1.5%
 
0.7%
-
1.0%
Restricted stock vesting criteria for market-based performance units issued [Table Text Block]
The percent of the target market-based performance vested restricted stock unit award that will be earned based on the Company's TSR relative to the peer group is as follows:
Percentile Rank
 
Percentage of
Units Vested
< 33%
 
0%
33%
 
50%
50%
 
100%
100%
 
150%
Valuation assumptions of Fiscal 2016 market-based restricted stock unit [Table Text Block]
Grant date fair values and derived service periods for each tranche were determined using a Monte Carlo valuation model based on assumptions, which included a weighted average risk-free interest rate of 1.5%, a weighted average expected life of 1.2 years and an implied volatility of 86% and were as follows for each tranche:
 
 
Fair Value (Per Share)
 
Derived Service Period
Tranche 1 (immediate)
 
$1.60
 
0 Years
Tranche 2 ($4.00/share)
 
$1.52
 
1.46 Years
Tranche 3 ($6.00/share)
 
$1.48
 
2.22 Years
Schedule of Non-vested Restricted Stock Activity [Table Text Block]
A summary of the status of the Company’s non-vested restricted stock unit activity as of February 2, 2019 and changes during the twelve-month period then ended is as follows:
 
Restricted Stock Units
 
Market-Based Units
 
Time-Based Units
 
Total
 
Shares
 
Weighted
Average
Grant Date
Fair Value
 
Shares
 
Weighted
Average
Grant Date
Fair Value
 
Shares
 
Weighted
Average
Grant Date
Fair Value
Non-vested outstanding, February 3, 2018
1,389,000

 
$
1.53

 
1,440,000

 
$
1.27

 
2,829,000

 
$
1.40

Granted
747,000

 
$
1.15

 
1,710,000

 
$
1.01

 
2,457,000

 
$
1.05

Vested

 
$

 
(1,088,000
)
 
$
1.23

 
(1,088,000
)
 
$
1.23

Forfeited
(507,000
)
 
$
1.56

 
(255,000
)
 
$
1.38

 
(762,000
)
 
$
1.50

Non-vested outstanding, February 2, 2019
1,629,000

 
$
1.35

 
1,807,000

 
$
1.04

 
3,436,000

 
$
1.18